Innovative Integration of Molecular Docking and Machine Learning for Drug Discovery: From Virtual Screening to Nanomolar Inhibitors

Mutasem O. Taha; Safa Daoud

doi:10.1039/d5cc06025g

January 1, 2026Chemical Communications

Innovative Integration of Molecular Docking and Machine Learning for Drug Discovery: From Virtual Screening to Nanomolar Inhibitors

View at Publisher

Ask AI

Bookmark

Share

Key Points

The aim is to showcase a systematic approach for drug discovery through the integration of molecular docking and machine learning techniques.
Integrating molecular docking with machine learning algorithms
Utilizing pharmacophore modeling for compound identification
Conducting virtual screening of potential bioactive leads
Identified novel strategies for efficient drug discovery
Demonstrated the effectiveness of nanomolar inhibitors
Provided a comprehensive framework for integrating computational methods

Abstract

This review highlights our group’s systematic approach to integrating molecular docking, pharmacophore modeling, and machine learning methodologies for the rational discovery of bioactive leads. We describe innovative strategies including docking-based...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Taha et al. (2026) studied this question.

synapsesocial.com/papers/69b3ab2902a1e69014ccbce0 https://doi.org/10.1039/d5cc06025g

View at Publisher

Ask AI

Bookmark

Share

Innovative Integration of Molecular Docking and Machine Learning for Drug Discovery: From Virtual Screening to Nanomolar Inhibitors

Key Points

Abstract

Discussion

Cite This Study

Innovative Integration of Molecular Docking and Machine Learning for Drug Discovery: From Virtual Screening to Nanomolar Inhibitors

Key Points

Abstract

Discussion

Cite This Study

Keep reading

Keep reading